Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cardiovascular Therapeutics|July 22, 2010
New antithrombotics for atrial fibrillationLuke R E Bereznicki, Gregory M Peterson
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 6, 2016
A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial FibrillationKehinde O Obamiro, Leanne Chalmers, Luke R E Bereznicki
Plos One|June 29, 2016
Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT)Kehinde O Obamiro, Leanne Chalmers, Luke R E Bereznicki
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|September 8, 2016
Factors associated with overestimation of asthma control: A cross-sectional study in AustraliaBonnie J Bereznicki, Millicent P Chapman, Luke R E Bereznicki
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 14, 2016
Anticoagulant Use in Patients With Nonvalvular Atrial Fibrillation: Has Prescribing Improved?Durga Bista, Leanne Chalmers, Gregory M Peterson, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 25, 2015
Patient Characteristics and Antithrombotic Prescribing Patterns in Patients With Atrial Fibrillation in TasmaniaDurga Bista, Leanne Chalmers, Gregory M Peterson, et al.
British Journal of Clinical Pharmacology|April 21, 2021
Pharmacist-led interventions to reduce adverse drug events in older people living in residential aged care facilities: A systematic reviewSheraz Ali, Mohammed S Salahudeen, Luke R E Bereznicki, et al.
Drug Safety|July 25, 2016
Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing FactorsMulugeta Tarekegn Angamo, Leanne Chalmers, Colin M Curtain, et al.
Pageof 3